- Presentations
- 5
- Markets
- 1
Imitrex is a brand of Sumatriptan marketed by GlaxoSmithKline, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sumatriptan
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 4 mg/0.5 mL injection, 6 mg/0.5 mL injection, 100 mg tablet, 25 mg tablet, 50 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Imitrex 4 mg/0.5 mL injectionSubcutaneous | GlaxoSmithKline | US FDA | Available on request |
| Imitrex 6 mg/0.5 mL injectionSubcutaneous | GlaxoSmithKline | US FDA | Available on request |
| Imitrex 100 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Imitrex 25 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
| Imitrex 50 mg tabletOral | GlaxoSmithKline | US FDA | Available on request |
Equivalent brands
Other brands of Sumatriptan.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Imitrex
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.